March 2025

PALMA DE MALLORCA, Spain, March 5, 2025 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative cancer therapy based on membrane lipid therapy, announced today optimistic results from its ongoing clinical trial evaluating LAM561 for the treatment of newly diagnosed glioblasto

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: